Overall market sentiment has been neutral on Co-Diagnostics Inc (CODX) stock lately. CODX receives a Neutral rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With CODX Stock Today?
Co-Diagnostics Inc (CODX) stock is trading at $9.22 as of 10:55 AM on Wednesday, Jun 9, an increase of $0.65, or 7.53% from the previous closing price of $8.57. The stock has traded between $8.64 and $9.43 so far today. Volume today is high. So far 1,178,852 shares have traded compared to average volume of 794,727 shares.
To see InvestorsObserver's Sentiment Score for Co-Diagnostics Inc click here.
More About Co-Diagnostics Inc
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
Click Here to get the full Stock Score Report on Co-Diagnostics Inc (CODX) Stock.
